Why Is Csx Transportation Interstitial Lung Disease So Effective Durin…
페이지 정보
작성자 Janell 작성일23-06-17 18:47 조회24회 댓글0건관련링크
본문
CSX Transportation Workers May Be At Risk For Chronic Lymphocytic Leukemia
Csx Transportation Lung Cancer (Sites.Google.Com) Transportation workers are at an elevated risk of leukemia because of exposure to benzene and butadiene and pesticides. Hartley Law Group PLLC filed two Federal Employers Liability Act lawsuits (FELA) on behalf of railroad employees who were diagnosed with Chronic Lymphocytic leukemia due to work-related exposures.
Leukemia is classified into four major types which are chronic, acute myelogenous and lymphocytic. The cancer cells target different blood cells, csx transportation lung cancer depending on the type of leukemia.
What is CLL?
CLL is a type of slow-growing of blood cancer. It starts in lymphocytes (white blood cells that fight infections) in the bone marrow and spreads into the bloodstream, leading to swollen glands (lymph nodes). Over time, Csx transportation lung cancer the accumulation of these unhealthy blood cell can cause weakness, fatigue and other signs. It's unclear what causes the abnormal lymphocytes to multiply and multiply, however, mutations in the DNA can cause the condition. These mutations may occur randomly or be passed down from parent to child. Mutations in certain chromosomes--including chromosome 13 and 17 --have been linked to CLL.
A CBC blood test can show low numbers of blood platelets. These aid in stopping bleeding and create blood clots. Signs of low platelets (thrombocytopenia) include bruising and swelling that is not painful, nose and gum bleeds as well as bleeding in the gastrointestinal tract or blood vessels.
Some patients with CLL that is growing slowly don't require immediate treatment. They can be monitored by the team of care. Others will require urgent treatment. The type of treatment used depends on whether the leukemia is growing rapidly or slowly, and also the patient's general health and age.
Immunotherapy drugs work by using your own immune system to fight lymphocytes that are cancerous. They can be administered by injection or an IV. Different side effects can be experienced however they tend to disappear with time.
What is the diagnosis for CLL?
For the most part, CLL is diagnosed when the patient is having blood tests conducted for another reason. It is not uncommon for patients who are not symptomatic to have the disease diagnosed through accident. It is possible for a patient to be diagnosed with the condition prior to symptoms onset through molecular or genetic testing.
Doctors can make use of molecular and genetic tests to determine the rate of the progression of cancer as well as how effective the treatment will be. The test can be conducted on a sample taken from the bone marrow or blood or the chromosomes inside these cells.
A immunophenotyping test that is genetically based can determine certain characteristics of cancer cells. In this test, a small amount of cells are passed through the machine that is able to detect a specific surface feature on each cell. If the cells are displaying that surface feature, they will light up on a screen when viewed under microscope. This can aid the doctor in determining the nature of the leukemia as well as its stage.
In certain cases the imaging test can be used to determine the location of the leukemia in the body. A computed tomography scan (CT) will reveal if leukemia is located in lymph nodes located in the abdomen, chest or pelvis. Herbicides can increase the risk for this type of cancer. CLL is more common among railroad workers who are exposed to herbicides like 2,4-D or paraquat.
Csx Transportation Lung Cancer (Sites.Google.Com) Transportation workers are at an elevated risk of leukemia because of exposure to benzene and butadiene and pesticides. Hartley Law Group PLLC filed two Federal Employers Liability Act lawsuits (FELA) on behalf of railroad employees who were diagnosed with Chronic Lymphocytic leukemia due to work-related exposures.
Leukemia is classified into four major types which are chronic, acute myelogenous and lymphocytic. The cancer cells target different blood cells, csx transportation lung cancer depending on the type of leukemia.
What is CLL?
CLL is a type of slow-growing of blood cancer. It starts in lymphocytes (white blood cells that fight infections) in the bone marrow and spreads into the bloodstream, leading to swollen glands (lymph nodes). Over time, Csx transportation lung cancer the accumulation of these unhealthy blood cell can cause weakness, fatigue and other signs. It's unclear what causes the abnormal lymphocytes to multiply and multiply, however, mutations in the DNA can cause the condition. These mutations may occur randomly or be passed down from parent to child. Mutations in certain chromosomes--including chromosome 13 and 17 --have been linked to CLL.
A CBC blood test can show low numbers of blood platelets. These aid in stopping bleeding and create blood clots. Signs of low platelets (thrombocytopenia) include bruising and swelling that is not painful, nose and gum bleeds as well as bleeding in the gastrointestinal tract or blood vessels.
Some patients with CLL that is growing slowly don't require immediate treatment. They can be monitored by the team of care. Others will require urgent treatment. The type of treatment used depends on whether the leukemia is growing rapidly or slowly, and also the patient's general health and age.
Immunotherapy drugs work by using your own immune system to fight lymphocytes that are cancerous. They can be administered by injection or an IV. Different side effects can be experienced however they tend to disappear with time.
What is the diagnosis for CLL?
For the most part, CLL is diagnosed when the patient is having blood tests conducted for another reason. It is not uncommon for patients who are not symptomatic to have the disease diagnosed through accident. It is possible for a patient to be diagnosed with the condition prior to symptoms onset through molecular or genetic testing.
Doctors can make use of molecular and genetic tests to determine the rate of the progression of cancer as well as how effective the treatment will be. The test can be conducted on a sample taken from the bone marrow or blood or the chromosomes inside these cells.
A immunophenotyping test that is genetically based can determine certain characteristics of cancer cells. In this test, a small amount of cells are passed through the machine that is able to detect a specific surface feature on each cell. If the cells are displaying that surface feature, they will light up on a screen when viewed under microscope. This can aid the doctor in determining the nature of the leukemia as well as its stage.
In certain cases the imaging test can be used to determine the location of the leukemia in the body. A computed tomography scan (CT) will reveal if leukemia is located in lymph nodes located in the abdomen, chest or pelvis. Herbicides can increase the risk for this type of cancer. CLL is more common among railroad workers who are exposed to herbicides like 2,4-D or paraquat.
댓글목록
등록된 댓글이 없습니다.
